• 1225 Citations
  • 16 h-Index
20052019
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • Ph.D., National Taiwan University

Research Interests

  • Tumor Biology
  • microRNA
  • Molecular cancer therapeutics

Experience

  • 2012/07~present Assistant Professor, Department of Medical Laboratory Science and Biotechnology, National Cheng-Kung University
  • 2010/08 - 2012/07Postdoctoral Fellow, Department of Oncology, College of Medicine, National Taiwan University
  • 2009/02 - 2010/07 Postdoctoral Fellow, Genomic Research Center, College of Medicine, National Taiwan University

Fingerprint Dive into the research topics where Pai-Sheng Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 39 Similar Profiles
Neoplasms Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Vascular Endothelial Growth Factor C Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Vascular Endothelial Growth Factor Receptor-3 Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Angiopoietins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2018

Research Output 2005 2019

Mutation of the PTCH1 gene predicts recurrence of breast cancer

Wang, C. Y., Chang, Y. C., Kuo, Y. L., Lee, K. T., Chen, P. S., Cheung, C. H. A., Chang, C. P., Phan, N. N., Shen, M. R. & Hsu, H. P., 2019 Nov 8, In : Scientific reports. 9, 1, 1 p., 16359.

Research output: Contribution to journalArticle

Open Access
Breast Neoplasms
Recurrence
Mutation
Genes
Computational Biology
1 Citation (Scopus)

TARBP2-enhanced resistance during tamoxifen treatment in breast cancer

Wang, M. Y., Huang, H. Y., Kuo, Y. L., Lo, C., Sun, H. Y., Lyu, Y. J., Chen, B. R., Li, J. N. & Chen, P. S., 2019 Feb, In : Cancers. 11, 2, 210.

Research output: Contribution to journalArticle

Open Access
RNA-Binding Proteins
Tamoxifen
HIV-1
Breast Neoplasms
Neurofibromin 2

TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

Lai, H., Li, C., Hong, C., Sun, H., Chiu, C., Ou, D. & Chen, P-S., 2019 Jan 18, In : Molecular Oncology.

Research output: Contribution to journalArticle

1 Citation (Scopus)

TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

Lai, H. H., Li, C. W., Hong, C. C., Sun, H. Y., Chiu, C. F., Ou, D. L. & Chen, P. S., 2019 Apr 1, In : Molecular Oncology. 13, 4, p. 928-945 18 p.

Research output: Contribution to journalArticle

Open Access
RNA-Binding Proteins
Response Elements
Transcriptional Activation
Hepatocellular Carcinoma
Neoplastic Stem Cells
10 Citations (Scopus)

Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses

Chang, J. H., Cheng, C. W., Yang, Y. C., Chen, W. S., Hung, W. Y., Chow, J. M., Chen, P-S., Hsiao, M., Lee, W. J. & Chien, M. H., 2018 Aug 22, In : Journal of Experimental and Clinical Cancer Research. 37, 1, 199.

Research output: Contribution to journalArticle

Dipeptidyl Peptidase 4
Apigenin
Gastropoda
Epidermal Growth Factor Receptor
Lung Neoplasms